31-03-2016 InnovativeExpansion and Financing Strategy

Replicon Corporate Finance assists a life science sector company in planning its global expansion strategy and simultaneously in financing this expansion.

Collaboration with local leading industrial player and maintaining global IPR rights has arisen as the main solution for this truly complicated multidimensional real world optimization task. With the combination of local partnership and global independence this relatively early phase company is able to receive the best present value / expected risk –ratio in the eyes of the risk capital investors.

Main risk in chosen strategy is a leakage of business secrets to rivals before definite agreements are signed. Precompiled non-disclosure agreements cannot protect against all illegitimate use of disclosed confidential information. Thus careful management of the disclosing and simultaneous IPR management is important in controlling these risks.        

For further information on this kind of services, please contact:

Petteri Hirvonen, CEO

Replicon Group, +358 50 552 96 33 (direct)

This email address is being protected from spambots. You need JavaScript enabled to view it.  

About Replicon Corporate Finance Ltd.

Replicon Corporate Finance Ltd. is an independent business development and corporate finance advisory house for growth companies and investors.

Replicon provides strategic and financial solutions that facilitate business activities, efficiency, and increase profitability of corporations and other organizations. Our core competence is in the corporate solutions that facilitate and govern growth of businesses based on innovation. Replicon Group’s special focus areas are Life Science and Cleantech sectors. Main shareholders in Replicon Group are its key management.